Tenax Therapeutics (TENX) Short-Term Debt repayments (2011 - 2015)

Tenax Therapeutics' Short-Term Debt repayments history runs 5 years deep, the most recent figure standing at $172025.0 for Q1 2015.

• In Q1 2015, Short-Term Debt repayments rose 103.62% year-over-year to $172025.0; the TTM figure through Dec 2015 stood at $172025.0 (changed N/A YoY), while the FY2015 annual figure was $172025.0, up 21.73% from the prior year.
• Short-Term Debt repayments came in at $172025.0 for Q1 2015 at Tenax Therapeutics, up from -$4.8 million in the prior quarter.
• In the past five years, Short-Term Debt repayments ranged from a high of $4.9 million in Q3 2013 to a low of -$4.8 million in Q1 2014.
• A 5-year average of $627045.4 and a median of $172025.0 in 2015 frame the typical range for Short-Term Debt repayments.
• Across the five-year window, Short-Term Debt repayments slumped 4730.2% in 2014 and surged 103.62% in 2015, its largest moves.
• Tenax Therapeutics' Short-Term Debt repayments stood at $700000.0 in 2011, then tumbled by 80.33% to $137692.0 in 2012, then sank by 118.15% to -$24995.0 in 2013, then plunged by 18919.28% to -$4.8 million in 2014, then surged by 103.62% to $172025.0 in 2015.
• According to Business Quant data, Short-Term Debt repayments over the past three periods registered $172025.0, -$4.8 million, and -$24995.0 for Q1 2015, Q1 2014, and Q4 2013 respectively.

Peer Comparison